Skip to content
In-house Gallium-68 generator · PSMA, DOTANOC & FAPI available daily · Complimentary pickup within 3 km
Neurad Diagnostic and Healthcare LLP Book a scan

PET CT Scan for Sarcoma — Grade, Biopsy Planning and the Coverage Error to Avoid

Sarcomas are uncommon, and that shapes almost everything about how they are diagnosed and imaged.

They arise in bone and in the soft tissues — muscle, fat, nerve sheath, blood vessel, connective tissue — anywhere in the body. There are dozens of subtypes with very different behaviour. And because they are rare, they are frequently mistaken for something benign for a considerable time before the right diagnosis is reached.

This guide explains where PET CT fits in sarcoma alongside MRI, why the biopsy route matters more here than in almost any other cancer, why the lungs get particular attention, how grade affects what a scan shows, and the preparation points for patients with large or painful tumours.

It also explains, clearly, why a scan is not what makes this diagnosis.

The most important point: MRI comes first for the tumour itself

If you have a lump in a limb or in the soft tissue of the trunk, and sarcoma is being considered, MRI is the primary imaging test.

The reason is what the treating team needs to know. Where exactly is the tumour? What compartment is it in? Does it involve the neurovascular bundle, the bone, the joint? Where are the tissue planes? Can it be removed with a clear margin, and what would that operation involve?

Those are questions about soft tissue anatomy measured in millimetres, and MRI answers them in a way nothing else does. Surgical planning and radiotherapy planning both depend on it.

A PET cannot answer them. It assesses metabolic activity, not tissue planes.

So if your orthopaedic oncologist has ordered an MRI and not a PET, that is correct practice, not an omission.

Why the biopsy route matters more here than anywhere else

This is unusual to find on a diagnostic centre’s website, and it is important enough to say plainly.

In sarcoma, where and how the biopsy is taken affects what surgery is possible later.

A biopsy track can seed tumour cells along its path. In sarcoma surgery, that track must be excised along with the tumour. If the biopsy was taken through the wrong compartment, or from a poorly chosen entry point, the surgery required to clear it becomes larger — and occasionally the difference between limb-preserving surgery and something more radical.

For this reason, the strong recommendation in sarcoma practice is that the biopsy should be planned by, or in discussion with, the surgical team who would perform the definitive operation — usually at a sarcoma unit.

What this means for you as a patient: if you have a suspected sarcoma, do not arrange a biopsy independently because it is quicker or more convenient. Ask your treating doctor who should perform it and where. A few days of coordination can protect the options available to you afterwards.

We offer image-guided biopsy, and we would still say the same thing: for a suspected sarcoma, the sarcoma surgical team should direct the approach.

Where PET CT does add value

Detecting distant spread, particularly to the lungs

Sarcomas spread predominantly through the bloodstream rather than the lymphatic system, and the lungs are by far the commonest destination.

This is a genuine difference from most carcinomas, where lymph node involvement dominates. In sarcoma, lymph node spread is relatively uncommon, and the lungs are what the team watches.

A CT of the chest is the standard test for lung assessment, because it resolves small pulmonary nodules better than PET. A whole-body PET adds the survey for disease elsewhere — bone, soft tissue, abdomen.

If your team has ordered both a chest CT and a PET, they are covering lung detail and whole-body survey respectively.

Assessing tumour grade

Grade — how aggressive a sarcoma is under the microscope — is one of the strongest determinants of behaviour and treatment.

Metabolic activity broadly tracks with grade. High-grade sarcomas tend to be strongly FDG-avid; low-grade tumours often show modest uptake. This does not replace pathology, which remains the basis of grading, but it contributes information.

Guiding where to biopsy within a large tumour

This is a genuinely useful and underappreciated use.

Large sarcomas are frequently heterogeneous — parts of the tumour may be high grade while other parts are lower grade or necrotic. A biopsy taken from a necrotic or low-grade area can under-grade the tumour, with real consequences for treatment.

A PET can identify the most metabolically active region, so the biopsy is directed there rather than taken from wherever is easiest to reach.

Assessing response to treatment

Where chemotherapy or radiotherapy is given before surgery, size on MRI may change little even when the tumour has responded substantially — because dead tumour occupies space. Metabolic change is often a better indicator of what has actually happened.

Suspected recurrence

After surgery and radiotherapy, the operated area contains scar tissue, and distinguishing scar from recurrent tumour on structural imaging alone is difficult. PET assesses activity, which helps.

Staging in specific subtypes

Some sarcoma subtypes — including certain childhood sarcomas — have established staging pathways in which PET plays a defined role. Your team will follow the protocol for your specific diagnosis.

Where PET has limitations in sarcoma

Small lung nodules. The commonest site of spread is the one where PET is weakest. Small pulmonary nodules fall below reliable metabolic detection, which is exactly why a dedicated chest CT is used rather than relying on the PET’s CT component.

Low-grade sarcomas. Many show modest uptake. A low SUV does not exclude sarcoma — it may simply reflect a low-grade tumour.

Certain subtypes. Myxoid and well-differentiated liposarcomas, among others, characteristically show low FDG uptake despite being significant tumours.

Local extent. As above, this is MRI territory.

Benign lesions that light up. Some benign soft tissue and bone lesions are metabolically active. Uptake alone does not establish malignancy — which is why tissue diagnosis remains essential.

Post-surgical and post-radiotherapy change. Healing tissue takes up the tracer, and radiotherapy inflammation persists. Timing matters.

Bone sarcomas

Osteosarcoma and Ewing sarcoma are the principal bone sarcomas, and they occur most often in adolescents and young adults.

Imaging typically involves plain radiographs and MRI of the affected bone for local assessment, a chest CT for lung assessment, and a whole-body study — PET or bone scan depending on the protocol and the diagnosis — for distant disease.

Ewing sarcoma in particular has established use of PET in staging and response assessment, including assessment of bone marrow involvement.

Two practical points for younger patients:

Radiation exposure matters more in a young person, and their treating team weighs this carefully when deciding which studies to order and how often. If you are the parent of a patient, it is entirely reasonable to ask what each scan will add.

Growth plates are metabolically active in children and adolescents, and this normal uptake is a recognised pattern that reporting physicians allow for.

Preparation, with large and painful tumours in mind

Coverage — check this

Sarcomas frequently arise in the limbs, and the standard PET field covers only skull base to mid-thigh. A tumour in the lower leg, foot, forearm or hand falls outside that field entirely.

Confirm that the protocol covers the site of your tumour. This is the most common practical error in sarcoma PET imaging, and it is entirely avoidable by asking at booking. Tell the centre exactly where your tumour is.

Positioning

Limb tumours may require specific positioning, and the affected limb may need to be placed in a particular way. A large tumour may make lying flat or fitting comfortably within the scanner more difficult.

Tell the centre the size and location of the tumour at booking so time and positioning can be planned rather than improvised.

Pain

Sarcomas are frequently painful, and the scan requires stillness during both the uptake period and the acquisition.

Ask whether to take your usual pain medication before coming — in most cases the answer is yes. Do not skip analgesia because you are fasting. A patient in pain is a patient who moves.

Recent biopsy or surgery

Biopsy tracks and surgical sites take up the tracer. Mention every procedure, its date and its location.

Fasting and blood sugar

Usually around 6 hours of fasting. Plain water allowed and encouraged. No tea, coffee, juice, sweets or chewing gum. Blood sugar checked before injection; diabetic patients should mention it at booking.

Avoid exertion

No strenuous activity for around 24 hours beforehand. Worked muscles take up the tracer — and in a scan assessing a soft tissue mass in a limb, muscle uptake in that limb is unhelpful.

Stay warm

Standard, for brown fat.

Tell the centre these things when you book

  1. Exactly where the tumour is — and whether it is outside the standard scan field
  2. The size of the tumour, if it is large
  3. Whether you have pain and take analgesia
  4. The date and site of any biopsy or surgery
  5. The dates of any chemotherapy or radiotherapy
  6. Whether you have any mobility difficulty or need help transferring
  7. Whether you have a prosthesis or metal implant, and where
  8. Whether you are diabetic, and what you take

What to bring

  • The prescription, with the clinical indication written on it
  • MRI of the primary site — films and report. This is the study the PET is read alongside
  • Chest CT, if performed
  • Plain radiographs, for bone sarcomas
  • Biopsy and histopathology reports, including subtype and grade
  • Previous PET scans, if any
  • Operative notes
  • Details of chemotherapy or radiotherapy, with dates
  • A list of current medications
  • Insurance or reimbursement papers, if you plan to file a claim
  • Photo identification

Subtype and grade deserve emphasis. With dozens of sarcoma subtypes behaving very differently, a reporting physician who knows which one you have interprets the images with the right expectations — including whether low uptake is expected for your tumour type.

Reading the report

A sarcoma PET report describes the primary tumour and its metabolic characteristics, notes any heterogeneity within it, then surveys the lungs, bone, soft tissues and abdomen.

Heterogeneity is worth understanding. A report describing varying uptake within the tumour is describing a tumour that is not uniform — which is relevant to where a biopsy should be taken.

SUVmax measures tracer accumulation adjusted for dose and weight. In sarcoma it broadly tracks with grade, but it does not replace pathology, and low uptake does not exclude sarcoma in subtypes known to be less avid.

Lung findings from the CT component should be read alongside a dedicated chest CT where one has been done, since that is the more sensitive test for small nodules.

The impression is the reporting physician’s summary and the part your sarcoma team reads first.

Radiation and safety

A PET CT involves ionising radiation from the tracer and the CT component. Many sarcoma patients are young, and cumulative exposure across a treatment course and long follow-up is something treating teams weigh deliberately.

Fluorine-18 has a half-life of under two hours, and essentially none remains active by the following day. Precautions afterwards are simple and temporary: drink water, and keep some distance from pregnant women and young children for the rest of the day.

If you are pregnant, breastfeeding or might be pregnant, raise it before the scan is scheduled.

What decides the cost

Sarcoma studies are usually FDG whole body, which is Rs 7,999* all-inclusive — the figure includes the scan, the tracer and the reporting, and nothing is added at the counter. Extended coverage to include the limbs is often required in sarcoma; send the prescription and we will confirm the complete figure for your exact study in writing.

*Rates as on date. The final all-inclusive rate is confirmed with you before booking.

If your team has also asked for an MRI of the primary site or a dedicated chest CT, those are separate investigations with their own costs. Our CT rates are published openly on our CT page.

Ask these before you book

  1. Does the protocol cover the site of my tumour? The most important question in sarcoma imaging.
  2. Is the tracer included in the figure you quoted?
  3. Is contrast included, if my protocol requires it?
  4. Is reporting included?
  5. What is the total I will pay at the counter? In writing.
  6. Will my MRI and histopathology be taken into account?
  7. Can you accommodate pain, a large tumour or limited mobility?
  8. When will the report be ready, and can it be before my appointment on [date]?

Where Neurad fits

Neurad Diagnostic and Healthcare LLP is a dedicated PET-CT and nuclear medicine centre at B-3, opposite Metro Pillar No. 233, near Paschim Vihar West Metro Station, New Multan Nagar, Paschim Vihar, New Delhi-110056. Monday to Saturday, 8:00 AM to 5:00 PM.

Studies are reported in-house by our nuclear medicine physicians — Dr. Swagat Dash (MBBS, DNB — Nuclear Medicine) and Dr. Pradeep Chaurasiya (MBBS, DNB — Nuclear Medicine, Molecular Imaging) — rather than outsourced.

Coverage confirmed against your tumour site before you come, so a limb tumour is not left outside the scan field. Tell us exactly where it is when you book.

Your MRI and histopathology taken into account, provided you bring them — subtype and grade change how the images are read.

Positioning and transfers planned in advance for large tumours, pain or limited mobility.

Written preparation instructions specific to your study, including guidance on taking pain medication before coming.

Blood sugar checked before injection as standard, with diabetic patients planned in advance.

Image-guided biopsy available — though for a suspected sarcoma we would advise, as above, that the approach is directed by the sarcoma surgical team who would perform the definitive operation.

CT services with rates published openly, if a dedicated chest CT has also been advised.

Complimentary pickup and drop within 3 km; beyond that, Rs 50 per km.

The all-inclusive figure in writing before you book.

Frequently asked questions

Why do I need an MRI as well as a PET?

They answer different questions. MRI defines the tumour’s exact location, compartment and relationship to nerves, vessels and bone — which determines what surgery is possible. PET assesses metabolic activity and surveys the body for distant disease. Neither can do the other’s job.

Can a PET scan diagnose sarcoma?

No. Diagnosis requires tissue. PET can suggest that a lesion is metabolically active and can indicate probable grade, but some benign lesions light up and some sarcomas do not. Biopsy remains essential.

Why does it matter who performs my biopsy?

Because in sarcoma the biopsy track has to be removed with the tumour at surgery. A poorly placed biopsy can make the necessary operation larger. The strong recommendation is that the biopsy is planned by or with the surgical team who would perform the definitive operation.

Why is a chest CT needed if I am having a PET?

Because sarcomas spread mainly to the lungs, and small pulmonary nodules are better detected by a dedicated chest CT than by PET. The two are complementary: lung detail and whole-body survey.

My tumour is in my calf. Will the scan cover it?

Not with standard coverage, which runs skull base to mid-thigh. This is the commonest practical error in sarcoma imaging. Tell the centre exactly where your tumour is when you book, and confirm the protocol covers it.

My SUV was low. Does that mean it is not sarcoma?

No. Low-grade sarcomas often show modest uptake, and certain subtypes — myxoid and well-differentiated liposarcomas among them — characteristically show low uptake despite being significant tumours. Pathology, not SUV, establishes the diagnosis.

Can PET help decide where to biopsy?

Yes, and this is a genuinely useful role. Large sarcomas are often heterogeneous, and a biopsy from a necrotic or low-grade area can under-grade the tumour. PET can identify the most metabolically active region so the biopsy is directed there.

My tumour has not shrunk after chemotherapy. Has it failed?

Not necessarily. Dead tumour still occupies space, so size on MRI may change little even when there has been a substantial response. Metabolic change is often a better indicator. Your team interprets both.

I have a lot of pain. Can I manage the scan?

Tell the centre at booking. Ask whether to take your usual pain medication before coming — usually the answer is yes, and fasting does not mean skipping analgesia. Positioning can also be planned in advance.

My child has Ewing sarcoma. Are repeated scans safe?

Radiation exposure in a young patient is something treating teams weigh carefully, and they order studies deliberately rather than routinely. It is entirely reasonable to ask what each scan will add and whether an alternative exists.

Do sarcomas spread to lymph nodes?

Relatively uncommonly compared with carcinomas. Sarcomas spread mainly through the bloodstream, with the lungs the commonest site — which is why lung imaging carries the emphasis it does.

What does a sarcoma PET CT cost?

Sarcoma studies are usually FDG whole body, which is Rs 7,999* all-inclusive of scan, tracer and reporting. Extended coverage to include the limbs, or contrast, can change the figure. Send the prescription on WhatsApp and we will share the all-inclusive figure for your exact study before you book.

Do I need a prescription?

Yes. A valid prescription is required for all PET CT studies, and it should state the clinical indication and the tumour site.

Related reading

Booking your scan

Send a photograph of the prescription to 8368225620 on WhatsApp. Include four things: exactly where your tumour is, whether it is large or painful, the dates of any biopsy or surgery, and the date of your next appointment with your treating team.

You will get the all-inclusive rate, confirmation that the protocol covers your tumour site, preparation instructions including guidance on pain medication, and a note on which imaging and reports to carry — the MRI and histopathology in particular.

Prefer to speak to someone? Call 8368225620 or 7011968879, Monday to Saturday, 8:00 AM to 5:00 PM.

This page is general information about the role of PET CT in sarcoma. It is not medical advice and must not be used to interpret your own report or to arrange a biopsy independently. Diagnosis, biopsy planning and treatment decisions in sarcoma should be directed by a specialist sarcoma team. A valid prescription is required for all PET CT studies.

Ready to book?Mon–Sat, 8 AM – 5 PM · Paschim Vihar

Book a scan Call
Book a scan Call now
Scroll to Top